{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:45:48Z","timestamp":1791805548801,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1K23HL159313"],"award-info":[{"award-number":["1K23HL159313"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001422","name":"American Society of Hematology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001422","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.thromres.2023.04.017","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T13:45:25Z","timestamp":1683121525000},"page":"150-155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review"],"prefix":"10.1016","volume":"226","author":[{"given":"Ellen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zain M.","family":"Virk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josanna","family":"Rodriguez-Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanny","family":"Al-Samkari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.04.017_bb0005","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist's perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2023.04.017_bb0010","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1182\/blood.2020008739","article-title":"Hereditary hemorrhagic telangiectasia: systemic therapies, guidelines, and an evolving standard of care","volume":"137","author":"Al-Samkari","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.04.017_bb0015","article-title":"Systemic antiangiogenic therapies for bleeding in hereditary hemorrhagic telangiectasia: a practical, evidence-based guide for clinicians","author":"Al-Samkari","year":"2022","journal-title":"Semin. Thromb. Hemost."},{"key":"10.1016\/j.thromres.2023.04.017_bb0020","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.thromres.2017.03.003","article-title":"Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: a cross-sectional survey","volume":"153","author":"Chaturvedi","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.04.017_bb0025","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1288\/00005537-199109000-00008","article-title":"The natural history of epistaxis in hereditary hemorrhagic telangiectasia","volume":"101","author":"Aa","year":"1991","journal-title":"Laryngoscope"},{"key":"10.1016\/j.thromres.2023.04.017_bb0030","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/thoraxjnl-2011-201076","article-title":"Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli\/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia","volume":"67","author":"Livesey","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.thromres.2023.04.017_bb0035","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH07-01-0064","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.017_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fgene.2015.00101","article-title":"Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia","volume":"6","author":"Shovlin","year":"2015","journal-title":"Front. Genet."},{"key":"10.1016\/j.thromres.2023.04.017_bb0045","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.25925","article-title":"Characterization of the rate, predictors, and thrombotic complications of thrombocytosis in iron deficiency anemia","author":"Song","year":"2020","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.thromres.2023.04.017_bb0050","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3324\/haematol.2020.270496","article-title":"Recognition of thrombotic risk of thrombocytosis in iron deficiency","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2023.04.017_bb0055","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.7326\/L21-0067","article-title":"Second international guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia","volume":"174","author":"Faughnan","year":"2021","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.thromres.2023.04.017_bb0060","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-4505-6-7","article-title":"Asking the right questions: scoping studies in the commissioning of research on the organisation and delivery of health services","volume":"6","author":"Anderson","year":"2008","journal-title":"Health Res. Policy Syst."},{"key":"10.1016\/j.thromres.2023.04.017_bb0065","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/s13023-019-1278-z","article-title":"Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group","volume":"14","author":"Gaetani","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.thromres.2023.04.017_bb0070","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.carrev.2022.04.005","article-title":"Left atrial appendage occlusion in hereditary haemorrhagic telangiectasia patients (Rendu Osler Syndrome) with non-valvular atrial fibrillation: prevention of cardioembolic events while avoiding the long-term risks of oral anticoagulation","volume":"43","author":"Cepas-Guillen","year":"2022","journal-title":"Cardiovasc. Revasc. Med."},{"key":"10.1016\/j.thromres.2023.04.017_bb0075","doi-asserted-by":"crossref","first-page":"537","DOI":"10.23736\/S2724-5683.20.05474-2","article-title":"Safety of reduced or absent antithrombotic therapy after left atrial appendage closure in patients affected by hereditary hemorrhagic telangiectasia and atrial fibrillation","volume":"70","author":"Pepe","year":"2022","journal-title":"Minerva Cardiol. Angiol."},{"key":"10.1016\/j.thromres.2023.04.017_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9061699","article-title":"Antithrombotic therapy in hereditary hemorrhagic telangiectasia: real-world data from the Gemelli Hospital HHT Registry","volume":"9","author":"Gaetani","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.thromres.2023.04.017_bb0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s13023-019-1172-8","article-title":"Natural history of patients with venous thromboembolism and hereditary hemorrhagic telangiectasia. Findings from the RIETE registry","volume":"14","author":"Riera-Mestre","year":"2019","journal-title":"Orphanet. J. Rare Dis."},{"key":"10.1016\/j.thromres.2023.04.017_bb0090","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jtha.2022.09.003","article-title":"Safety, tolerability, and effectiveness of anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia","volume":"21","author":"Virk","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.017_bb0095","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2023.04.017_bb0100","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/joim.12832","article-title":"Systemic bevacizumab for the treatment of chronic bleeding in hereditary haemorrhagic telangiectasia","volume":"285","author":"Al-Samkari","year":"2019","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.thromres.2023.04.017_bb0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/0194599818813521","article-title":"Systemic bevacizumab for hereditary hemorrhagic telangiectasia: considerations from observational studies","volume":"160","author":"Al-Samkari","year":"2019","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.thromres.2023.04.017_bb0110","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/hae.14034","article-title":"An international survey to evaluate systemic bevacizumab for chronic bleeding in hereditary haemorrhagic telangiectasia","volume":"26","author":"Al-Samkari","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2023.04.017_bb0115","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jth.15715","article-title":"A precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies","volume":"20","author":"Al-Samkari","year":"2022","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.017_bb0120","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s10456-021-09807-4","article-title":"Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia","volume":"25","author":"Parambil","year":"2022","journal-title":"Angiogenesis"},{"key":"10.1016\/j.thromres.2023.04.017_bb0125","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1111\/jth.15410","article-title":"Vascular abnormalities in patients with von Willebrand disease: a scoping review","volume":"19","author":"Chornenki","year":"2021","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.017_bb0130","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/rth2.12481","article-title":"Acquired von Willebrand syndrome in monoclonal gammopathy - a scoping review on hemostatic management","volume":"5","author":"Abou-Ismail","year":"2021","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.017_bb0135","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/rth2.12204","article-title":"Using pharmacokinetics for tailoring prophylaxis in people with hemophilia switching between clotting factor products: a scoping review","volume":"3","author":"Yu","year":"2019","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.04.017_bb0140","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1111\/hae.12596","article-title":"Cardiovascular disease prevalence and relevance in haemophilia: a scoping review","volume":"21","author":"Rizwan","year":"2015","journal-title":"Haemophilia"},{"key":"10.1016\/j.thromres.2023.04.017_bb0145","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1756-0500-7-264","article-title":"The clinical case report: a review of its merits and limitations","volume":"7","author":"Nissen","year":"2014","journal-title":"BMC Res. Notes"},{"key":"10.1016\/j.thromres.2023.04.017_bb0150","doi-asserted-by":"crossref","first-page":"e472","DOI":"10.1016\/S2352-3026(21)00164-2","article-title":"Giving hereditary haemorrhagic telangiectasia the attention it deserves","volume":"8","author":"Al-Samkari","year":"2021","journal-title":"Lancet Haematol."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:45Z","timestamp":1758736305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":30,"alternative-id":["S0049384823001093"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.04.017","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anticoagulation and antiplatelet therapy in hereditary hemorrhagic telangiectasia: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.04.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}